General article
A place for ipratropium bromide in the treatment of severe acute asthma

https://doi.org/10.1016/0007-0971(85)90071-3Get rights and content

Abstract

Twenty-four consecutive patients admitted to hospital with severe acute asthma were studied. Eleven were given 10 mg salbutamol by nebulizer followed 2 hours later by 500 μg of nebulized ipratropium bromide. These patients had a greater response in PEFR than 13 patients given two doses of 10 mg salbutamol 2 hours apart.

References (10)

There are more references available in the full text version of this article.

Cited by (57)

  • Life-Threatening Asthma

    2008, Critical Care Medicine: Principles of Diagnosis and Management in the Adult
  • Metaanalytic revision of endpoints

    1999, Annals of Emergency Medicine
View all citing articles on Scopus

Present address: Department of Tuberculosis & Chest Diseases, University of Wales College of Medicine, Llandough Hospital, Penarth, South Glamorgan CF6 1XX.

View full text